Are reactive oxygen species still the basis for diabetic complications?
about
An Overview of Murine High Fat Diet as a Model for Type 2 Diabetes MellitusDiabetic Retinopathy: Animal Models, Therapies, and PerspectivesClinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical ConsiderationsAPX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury.Vascular Impairment of Epineurial Arterioles of the Sciatic Nerve: Implications for Diabetic Peripheral Neuropathy.Nitric oxide in the pathophysiology of retinopathy: evidences from preclinical and clinical researches.Reactive oxygen species: sources, consequences and targeted therapy in type 2 diabetes.Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implications.Tocotrienol and Its Role in Chronic Diseases.Free radical scavenging decreases endothelin-1 excretion and glomerular albumin permeability during type 1 diabetes.Long non-coding RNA ASncmtRNA-2 is upregulated in diabetic kidneys and high glucose-treated mesangial cells.NOX4-derived reactive oxygen species limit fibrosis and inhibit proliferation of vascular smooth muscle cells in diabetic atherosclerosis.Oxidative stress and reactive oxygen species: a review of their role in ocular disease.Oxidative Stress-Responsive Apoptosis Inducing Protein (ORAIP) Plays a Critical Role in High Glucose-Induced Apoptosis in Rat Cardiac Myocytes and Murine Pancreatic β-Cells.Diosmin Modulates the NF-kB Signal Transduction Pathways and Downregulation of Various Oxidative Stress Markers in Alloxan-Induced Diabetic Nephropathy.
P2860
Q26740006-0ABB80EB-37A5-4C3C-8DF6-B0A93D01D722Q26765466-51E8C43D-4DB0-4913-BD68-D47656F3FF63Q37011769-C12FF15C-354B-4F8A-872B-08781E165CC6Q38406031-640DA86F-E6ED-44AD-B880-4222C910C0E9Q38671591-B5F73EEA-A94A-47ED-8406-36A6BB76025AQ38845903-74865FD8-D95B-4930-8F1F-2A0EBC84599DQ38880678-90A5E8D8-5236-46E7-A9D9-3BF09551AD14Q38913007-1ABFB9D6-5802-4250-8305-2F4BC48646AFQ38965196-693379ED-7437-4A05-A833-30A9C9B86081Q39048549-3DA9DDB9-1830-45B3-B3C7-8950D4D0A725Q42132596-C6145663-8B89-4324-ABA4-2CEF472ADDDDQ42160197-B15706C1-131B-41D8-BF28-2B3807D444E4Q46248374-E28F7088-59CC-4C11-9D1D-7686AD40B6AFQ47618498-834DDF79-6F7B-490D-B7A9-0CA1D3730524Q51593952-D8F3364E-E7CE-4D9D-8BC5-F68329B16CF6
P2860
Are reactive oxygen species still the basis for diabetic complications?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Are reactive oxygen species still the basis for diabetic complications?
@en
type
label
Are reactive oxygen species still the basis for diabetic complications?
@en
prefLabel
Are reactive oxygen species still the basis for diabetic complications?
@en
P2093
P2860
P356
P1433
P1476
Are reactive oxygen species still the basis for diabetic complications?
@en
P2093
Arpeeta Sharma
Elyse Di Marco
Karin A Jandeleit-Dahm
P2860
P304
P356
10.1042/CS20150093
P407
P577
2015-07-01T00:00:00Z